Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000649854 | SCV000771688 | benign | Inflammatory skin and bowel disease, neonatal, 1 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV000649854 | SCV003920636 | likely benign | Inflammatory skin and bowel disease, neonatal, 1 | 2022-07-12 | criteria provided, single submitter | clinical testing | This variant has been reported in the literature in association with inflammatory bowel disease (Gettler 2021 PMID:33359885). However, this variant is present in the Genome Aggregation Database (Highest reported MAF 1.2% (196/15286) including multiple homozygotes (https://gnomad.broadinstitute.org/variant/2-9492963-C-T?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:539952). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant suggests that this variant does not cause disease but requires further evidence. Therefore, this variant is classified as likely benign. |
Breakthrough Genomics, |
RCV004708978 | SCV005240498 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003980263 | SCV004797765 | benign | ADAM17-related disorder | 2019-06-27 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |